Rhenman & Partners Asset Management Ab Silk Road Medical Inc Transaction History

Rhenman & Partners Asset Management Ab

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$38.09 - $57.79 $966,876 - $1.47 Million	25,384 Added 12.96%	221,255 $8.66 Million
Q4 2022 Feb 13, 2023	BUY	$40.54 - $56.2 $1.66 Million - $2.3 Million	40,871 Added 26.37%	195,871 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$36.98 - $49.2 $739,599 - $984,000	-20,000 Reduced 11.43%	155,000 $6.83 Million
Q2 2022 Aug 12, 2022	BUY	$28.03 - $45.8 $700,750 - $1.15 Million	25,000 Added 16.67%	175,000 $6.37 Million
Q1 2022 May 13, 2022	SELL	$29.24 - $44.06 $1.46 Million - $2.2 Million	-50,000 Reduced 25.0%	150,000 $6.19 Million
Q4 2021 Feb 11, 2022	BUY	$39.32 - $61.61 $2.12 Million - $3.33 Million	54,000 Added 36.99%	200,000 $8.66 Million
Q1 2021 May 14, 2021	BUY	$46.31 - $62.7 $972,510 - $1.32 Million	21,000 Added 16.8%	146,000 $7.4 Million
Q4 2020 Jan 19, 2021	SELL	$55.51 - $69.94 $832,650 - $1.05 Million	-15,000 Reduced 10.71%	125,000 $7.87 Million
Q2 2020 Jul 16, 2020	SELL	$27.55 - $43.28 $964,250 - $1.51 Million	-35,000 Reduced 20.0%	140,000 $5.87 Million
Q1 2020 Apr 16, 2020	SELL	$23.16 - $47.8 $796,263 - $1.64 Million	-34,381 Reduced 16.42%	175,000 $5.51 Million
Q4 2019 Jan 17, 2020	BUY	$27.97 - $40.38 $2.36 Million - $3.41 Million	84,381 Added 67.5%	209,381 $8.46 Million
Q3 2019 Oct 16, 2019	BUY	$31.65 - $46.94 $3.96 Million - $5.87 Million	125,000 New	125,000 $4.07 Million

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.